Plus Therapeutics Insider Trades

PSTV

Track insider trading activity from Plus Therapeutics executives and directors. See which insiders are buying and selling PSTV stock.

Trades Last 12 Months

PSTV Price

All Insider Trades for Plus Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sims Andrew John Hugh Mac Intyre Chief Financial Officer
Holding Value $18.7k 3,443 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.8k 3,443 shares
$5.76
$5.42
Holding Value $20k 3,686 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.2k 3,686 shares
$5.76
$5.42
Holding Value $20k 3,686 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 7,372 shares
$5.76
$5.42
Clowes Howard Director
Holding Value $20k 3,686 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 7,372 shares
$5.76
$5.42
Hedrick Marc H Chief Executive Officer
Holding Value $129k 23,834 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$137k 23,834 shares
$5.76
$5.42
Guse Kyle Director
Holding Value $20k 3,686 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 7,372 shares
$5.76
$5.42
Holding Value $20k 3,686 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.2k 3,686 shares
$5.76
$5.42
Daniels Eric Joseph Chief Development Officer
Holding Value $108k 20,000 shares
Last Trade
Apr 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$292k 40,000 shares
$7.30
$5.42
Sims Andrew John Hugh Macintyre Chief Financial Officer
Holding Value $261k 48,138 shares
Last Trade
Oct 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.6k 38,323 shares
$0.67
$5.42
Lenk Robert P Director
Holding Value $755k 139,327 shares
Last Trade
Aug 22, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$53.9k 110,000 shares
$0.49
$5.42
Holding Value $1.61M 297,794 shares
Last Trade
Aug 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 297,794 shares
$0.57
$5.42
Petersen Greg Director
Holding Value $217k 40,122 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.3k 40,122 shares
$1.18
$5.42
Lafrance Norman D. Chief Medical Officer
Holding Value $130k 24,073 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.9k 24,073 shares
$2.03
$5.42
Girao Tiago VP & Chief Financial Officer
Holding Value $5.69k 1,050 shares
Last Trade
Jul 25, 2018 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$757 1,051 shares
$0.72
$5.42
Postfinance Ag 10% owner
Holding Value $24.6M 4,543,086 shares
Last Trade
Feb 14, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.7M 473,831 shares
$3.59
$5.42
Swissquote Bank Sa 10% owner
Holding Value $29.8M 5,496,655 shares
Last Trade
Jan 09, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$72k 20,000 shares
$3.60
$5.42
Rickey David Director
Holding Value $32.5 6 shares
Last Trade
Nov 28, 2017 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$428k 6 shares
$71,250.00
$5.42
Lyons Gary A Director
Holding Value $0 0 shares
Last Trade
Nov 28, 2017 Sale (In The Money)Reported as In The Money on SEC Form 4.
$3.76 1 shares
$3.76
$5.42
Harris John David VP And GM Cell Therapy
Holding Value $5.42 1 shares
Last Trade
Nov 28, 2017 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$71.3k 1 shares
$71,250.00
$5.42
Naughton Gail K Director
Holding Value $0 0 shares
Last Trade
Nov 28, 2017 Sale (In The Money)Reported as In The Money on SEC Form 4.
$71.3k 1 shares
$71,250.00
$5.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up